Tsujimae Kenji, Suzuki Shingo, Murakami Shingo, Kurachi Yoshihisa
Division of Molecular and Cellular Pharmacology, Department of Pharmacology, Graduate School of Medicine, Osaka University, 2-2 Yamada-oka, Suita, Osaka 565-0871, Japan.
Am J Physiol Heart Circ Physiol. 2007 Jul;293(1):H660-9. doi: 10.1152/ajpheart.01083.2006. Epub 2007 Jan 12.
Rapidly activating K(+) current (I(Kr)) blockers prolong action potential (AP) duration (APD) in a reverse-frequency-dependent manner and may induce arrhythmias, including torsade de pointes in the ventricle. The I(Kr) blocker dofetilide has been approved for treatment of atrial arrhythmias, including fibrillation. There are, however, a limited number of studies on the action of I(Kr) blockers on atrial AP. When we tested a mathematical model of the human atrial AP (M Courtemanche, RJ Ramirez, S Nattel. Am J Physiol Heart Circ Physiol 275: H301-H321, 1998) to examine the effects of dofetilide-type I(Kr) blockade, this model could not reproduce the reverse-frequency-dependent nature of I(Kr) blockade on atrial APD. We modified the model by introducing a slowly activating K(+) current activation parameter. As the slow time constant was increased, dofetilide-type blockade induced more prominent reverse-frequency-dependent APD prolongation. Using the modified model, we also examined the effects of two more types of I(Kr) blockade similar to those of quinidine and vesnarinone. Voltage- and time-dependent block of I(Kr) through the onset of inhibition by quinidine is much faster than by vesnarinone. When we incorporated the kinetics of the effects of these drugs on I(Kr) into the model, we found that quinidine-type blockade caused a reverse-frequency-dependent prolongation of APD that was similar to the effect of dofetilide-type blockade, whereas vesnarinone-type blockade did not. This finding coincides with experimental observations. The lack of the reverse frequency dependence in vesnarinone-type blockade was accounted for by the slow development of I(Kr) blockade at depolarized potentials. These results suggest that the voltage- and time-dependent nature of I(Kr) blockade by drugs may be critical for the phenotype of the drug effect on atrial AP.
快速激活钾电流(I(Kr))阻滞剂以反向频率依赖性方式延长动作电位(AP)时程(APD),并可能诱发心律失常,包括心室尖端扭转型室速。I(Kr)阻滞剂多非利特已被批准用于治疗房性心律失常,包括房颤。然而,关于I(Kr)阻滞剂对心房AP作用的研究数量有限。当我们测试人类心房AP的数学模型(M·库尔特曼什、RJ·拉米雷斯、S·纳特尔。《美国生理学杂志·心脏和循环生理学》275:H301 - H321,1998)以研究多非利特型I(Kr)阻滞的作用时,该模型无法重现I(Kr)阻滞对心房APD的反向频率依赖性特征。我们通过引入一个缓慢激活的钾电流激活参数对模型进行了修改。随着慢时间常数增加,多非利特型阻滞诱导出更显著的反向频率依赖性APD延长。使用修改后的模型,我们还研究了另外两种类似于奎尼丁和维纳卡兰的I(Kr)阻滞类型的作用。通过奎尼丁开始抑制而产生的I(Kr)的电压和时间依赖性阻滞比维纳卡兰快得多。当我们将这些药物对I(Kr)作用的动力学纳入模型时,我们发现奎尼丁型阻滞导致APD的反向频率依赖性延长,这与多非利特型阻滞的作用相似,而维纳卡兰型阻滞则没有。这一发现与实验观察结果一致。维纳卡兰型阻滞中缺乏反向频率依赖性是由去极化电位下I(Kr)阻滞的缓慢发展所导致的。这些结果表明,药物对I(Kr)阻滞的电压和时间依赖性性质可能对药物对心房AP作用的表型至关重要。